EN
HI
Pharmaids Pharmaceuticals Share Price
PHARMAID
30.150.75 (2.55%)
Last updated on 1 Oct, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 2 Oct, 2026, Pharmaids Pharmaceuticals stock price is ₹30.15. During the trading session, the stock has moved between an intraday low of ₹29.51 and an intraday high of ₹30.40. Over the last 52 weeks, Pharmaids Pharmaceuticals has traded between ₹25.60 and ₹60.79.
The stock has recorded a trading volume of 2,722 shares,. Its Average Traded Price (ATP) is ₹29.94, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 93 @ ₹30.15.
Pharmaids Pharmaceuticals has an upper circuit limit of ₹36.18 and a lower circuit limit of ₹24.12. The total value traded stands at ₹81496.68, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Pharmaids Pharmaceuticals also offers a dividend yield of 0%.
Pharmaids Pharmaceuticals Share Price Chart
Pharmaids Pharmaceuticals Share Key Metrics
Volume
2722.00
Market Cap
106.33 CR
LTQ@LTP
93@30.15
ATP
29.94
Var Margin
25 %
Circuit Range
24.12-36.18
Delivery %
0 %
Value
81496.68
ASM/GSM
No
Market Lot
1
Pharmaids Pharmaceuticals Resistance and Support
Pivot 29.7
Resistance
First Resistance
30.1
Second Resistance
30.8
Third Resistance
31.2
Support
First Support
29
Second Support
28.6
Third Support
27.9
Pharmaids Pharmaceuticals Shareholding Pattern
View More- 2023-24
- 2022-23
- 2021-22
- 2020-21
- 2016-17
- 2024-25
- 2019-20
- 2018-19
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
32.99%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
67.01%
Others
0%
Total Promoters
MAR '26
32.99%
JUN '26
32.99%
Pharmaids Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-23 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
Pharmaids Pharmaceuticals News
Pharmaids Pharmaceuticals Ltd - 524572 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pharmaids Pharmaceuticals filed two legal complaints against M/s Anugraha Chemicals and its partners. The complaints seek recovery of ₹2.625 crore for two dishonored cheques, which were issued as part of a disinvestment agreement.
Sep 16 2026 17:51:01
Pharmaids Pharmaceuticals Management
| Name | Position |
|---|---|
| Prasanna Subramanya Bhat | Company Secretary & Compliance Officer |
| Shankarappa Nagaraja Vinaya Babu | Vice Chairman |
Pharmaids Pharmaceuticals Similar Stocks
Mercury Laboratories Ltd.
748.00
-2.00 (0.27%)
Himalaya Nutravedics India Ltd.
122.60
5.80 (4.97%)
Asston Pharmaceuticals Ltd.
97.40
-0.10 (0.10%)
Bharat Immunologicals & Biologicals Corporation Ltd.
8.18
-0.88 (9.71%)
Modern Diagnostic & Research Centre Ltd.
71.90
-1.35 (1.84%)
Concord Drugs Ltd.
75.70
1.17 (1.57%)
Everest Organics Ltd.
220.70
-0.80 (0.36%)
Godavari Drugs Ltd.
118.95
-1.67 (1.38%)
Pharmaids Pharmaceuticals FAQs
The Buying Price of Pharmaids Pharmaceuticals share is 30.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Pharmaids Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Pharmaids Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Pharmaids Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Pharmaids Pharmaceuticals shares is 2.09. Useful to assess the stock's value relative to its book value.
To assess Pharmaids Pharmaceuticals’s valuation compare Sector P/E, P/B which are 43.03 & 3.62 with sector averages, along with growth rates and financial metrics.
The Market Cap of Pharmaids Pharmaceuticals is 106.33 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Pharmaids Pharmaceuticals share price is 60.79 & 25.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Pharmaids Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in PHARMAID
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC